Two Sigma Investments
TMBR

Two Sigma Investments’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Two Sigma Investments’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-872
Closed -$17K – 3119
2022
Q1 		$17K Sell
872
-254
-23% -$4.23K ﹤0.01% 2531
2021
Q4 		$21K Buy
1,126
+843
+298% +$23.9K ﹤0.01% 4172
2021
Q3 		$13K Buy
+283
New +$13.9K ﹤0.01% 4174
2019
Q3 		– Sell
-32
Closed -$12K – 3901
2019
Q2 		$12K Buy
+32
New +$24.9K ﹤0.01% 3268

Other funds holding TMBR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Two Sigma Investments's TMBR Position: Q2 2022 in Review

Two Sigma Investments sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2022, closing a stake of 872 shares — an estimated $17K sold.

Two Sigma Investments first reported a position in TMBR in Q2 2019 and held it in 4 quarters. The position peaked at $21K in Q4 2021. 13 funds tracked by Wall St. Rank hold TMBR as of Q2 2022.

  • Two Sigma Investments reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Investments sold 872 Timber Pharmaceuticals, Inc. shares in Q2 2022, an estimated $17K.
  • Two Sigma Investments first reported a position in Timber Pharmaceuticals, Inc. in Q2 2019 and held it in 4 quarters.
  • Two Sigma Investments's Timber Pharmaceuticals, Inc. position peaked at $21K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.